Cas:7537-08-8 2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile manufacturer & supplier

Chemical Name:2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile

CAS.NO:7537-08-8

Synonyms:3,4-DIMETHOXY-2-FLUOROPHENYLACETONITRILE;2-fluorohomoveratronitrile;2-Fluoro-3,4-dimethoxyphenylacetonitrile;Benzylcynide,2-fluoro-3,4-dimethoxy

Molecular Formula:C₁₀H₁₀FNO₂

Molecular Weight:195.19000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:42.25000

Exact Mass:195.07000

LogP:1.90898

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3,4-DIMETHOXY-2-FLUOROPHENYLACETONITRILE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzylcynide,2-fluoro-3,4-dimethoxy physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3,4-DIMETHOXY-2-FLUOROPHENYLACETONITRILE Use and application,2-Fluoro-3,4-dimethoxyphenylacetonitrile technical grade,usp/ep/jp grade.

Related News: However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile manufacturer Many domestic raw material pharmaceutical and intermediate manufacturing companies with strong capital and talent reserves and advanced technology and processes have developed in the country, and the competitiveness of market participants has continued to increase. 2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile supplier Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile vendor Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. 2-(2-fluoro-3,4-dimethoxyphenyl)acetonitrile factory Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement.